News

Hosted on MSN10d
As antibiotic resistance grows, study showing how superbugs kill others offers hope
In their study, Van Tyne and Mills wanted to explore whether these hardy bacteriocin-producing bacteria were unique to UPMC ...
Seeking Alpha3d
Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update
Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides ... vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus ...
Nasdaq16d
Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides ... vancomycin resistant Enterococcus (VRE), drug- resistant Streptococcus ...
Nasdaq5d
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides ... vancomycin resistant Enterococcus (VRE), drug- resistant Streptococcus ...
Walla Walla Union Bulletin21d
Pitt research points to solution for growing problem of bacteria resistance
they wanted to explore whether these hardy bacteriocin-producing bacteria were unique to UPMC and the 710 sample pool. Using a global genetic sequencing database of 15,000 VRE samples taken from ...
Yahoo Finance12d
Veris Residential Inc (VRE) Q4 2024 Earnings Call Highlights: Strong NOI Growth and Strategic ...
2025 Expense Growth Projection: 2.6% to 3%. Veris Residential Inc (NYSE:VRE) successfully pivoted away from office exposure, executing large-scale asset sales at advantageous pricing. The company ...